Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells. Academic Article uri icon

Overview

abstract

  • Regulatory T (Treg) cells have an immunosuppressive function and highly express the immune checkpoint receptor PD-1 in the tumor microenvironment; however, the function of PD-1 in tumor-infiltrating (TI) Treg cells remains controversial. Here, we showed that conditional deletion of PD-1 in Treg cells delayed tumor progression. In Pdcd1fl/flFoxp3eGFP-Cre-ERT2(+/-) mice, in which both PD-1-expressing and PD-1-deficient Treg cells coexisted in the same tissue environment, conditional deletion of PD-1 in Treg cells resulted in impairment of the proliferative and suppressive capacity of TI Treg cells. PD-1 antibody therapy reduced the TI Treg cell numbers, but did not directly restore the cytokine production of TI CD8+ T cells in TC-1 lung cancer. Single-cell analysis indicated that PD-1 signaling promoted lipid metabolism, proliferation and suppressive pathways in TI Treg cells. These results suggest that PD-1 ablation or inhibition can enhance antitumor immunity by weakening Treg cell lineage stability and metabolic fitness in the tumor microenvironment.

authors

  • Kim, Myeong Joon
  • Kim, Kyungsoo
  • Park, Hyo Jin
  • Kim, Gil-Ran
  • Hong, Kyeong Hee
  • Oh, Ji Hoon
  • Son, Jimin
  • Park, Dong Jin
  • Kim, Dahae
  • Choi, Je-Min
  • Lee, Insuk
  • Ha, Sang-Jun

publication date

  • December 28, 2022

Research

keywords

  • Neoplasms
  • T-Lymphocytes, Regulatory

Identity

Scopus Document Identifier

  • 85145034017

Digital Object Identifier (DOI)

  • 10.1038/s41590-022-01373-1

PubMed ID

  • 36577929

Additional Document Info

volume

  • 24

issue

  • 1